Perioperative durvalumab has “the potential to transform the standard of care” for patients with muscle-invasive bladder ...

Module 1 Selected Case Studies: NUC-3373 plus pembrolizumab in patients with advanced solid tumors: 72-year-old patient with urothelial bladder cancer who had previously received gemcitabine plus ...

The gemcitabine and cisplatin combination has ... chemotherapy regimen in elderly patients with muscle-invasive bladder cancer. Notwithstanding all of the above considerations, many have indicated ...

The phase 3 NIAGARA trial evaluated this regimen in cisplatin-eligible patients with muscle-invasive bladder cancer, relative to neoadjuvant gemcitabine–cisplatin and surgery alone. Event-free ...

These studies indicate that administration of low-dose cisplatin and gemcitabine is safe and feasible in bladder cancer patients with impaired renal function and shows adequate levels of efficacy.

5 investigated intravesical gemcitabine/docetaxel as rescue therapy for NMIBC ... is approved by the US FDA for patients with BCG-unresponsive non-muscle-invasive bladder cancer with CIS with/without ...

Patients with Advanced Solid Tumors who had Exhausted All Other Treatment Options and were PD-(L)1 Experienced Achieved Significant Tumor Volume Reductions and Prolonged Progression Free Survival Foll ...

Rana R. McKay, MD, discusses the significance of clinical trial data for immunotherapy in muscle-invasive bladder cancer (MIBC) treatment she presented at a Case-Based Roundtable event.

Combination therapy with enfortumab vedotin (Padcev) and pembrolizumab (Keytruda) was associated with durable responses and ...

(UroToday.com) The 2024 South Central AUA annual meeting included a session on bladder cancer, featuring a presentation by ... should be prioritized for induction BCG over maintenance Gemcitabine, ...

bladder cancer using gemcitabine and conformal radiotherapy (RT). Methods: 30 TCC patients with good performance status and renal function subjected to maximum trans-urethral resection of bladder ...